T-cell prolymphocytic leukemia medical therapy: Difference between revisions
Carlos Lopez (talk | contribs) |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
==Medical Therapy== | ==Medical Therapy== | ||
T-cell prolymphocytic leukemia responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are:<ref name=T-PLL>{{cite web | title = Canadian Cancer Society| url =http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/prolymphocytic-leukemias/?region=on }}</ref> | ===Chemotherapy=== | ||
T-cell prolymphocytic leukemia responds better when combinations of [[chemotherapy]] drugs are used. Some combinations that may be used are:<ref name=T-PLL>{{cite web | title = Canadian Cancer Society| url =http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/prolymphocytic-leukemias/?region=on }}</ref> | |||
* CVP – [[Cyclophosphamide]], [[vincristine]] and [[prednisone]]. | * CVP – [[Cyclophosphamide]], [[vincristine]] and [[prednisone]]. | ||
| Line 23: | Line 25: | ||
===Biological therapy=== | ===Biological therapy=== | ||
Monoclonal antibodies are a type of biological therapy that has been effective in treating certain types of [[leukemias]]. These drugs may be used alone or in combination with chemotherapy to treat prolymphocytic leukemia. | Monoclonal antibodies are a type of [[biological therapy]] that has been effective in treating certain types of [[leukemias]]. These drugs may be used alone or in combination with chemotherapy to treat prolymphocytic leukemia. | ||
* [[Alemtuzumab]] seems to be particularly effective in treating T-cell prolymphocytic leukemia. It may be used in people whose [[lymphoma]] is no longer responding to chemotherapy drugs like [[fludarabine]]. | * [[Alemtuzumab]] seems to be particularly effective in treating T-cell prolymphocytic leukemia. It may be used in people whose [[lymphoma]] is no longer responding to chemotherapy drugs like [[fludarabine]]. | ||
Revision as of 15:26, 30 September 2015
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia medical therapy On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia medical therapy |
|
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]
Overview
Medical Therapy
Chemotherapy
T-cell prolymphocytic leukemia responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are:[1]
- CVP – Cyclophosphamide, vincristine and prednisone.
- CHOP – Cyclophosphamide, doxorubicin, vincristine and prednisone.
Other chemotherapy drugs (purine analogues) are often used to treat T-cell prolymphocytic leukemia are:
Biological therapy
Monoclonal antibodies are a type of biological therapy that has been effective in treating certain types of leukemias. These drugs may be used alone or in combination with chemotherapy to treat prolymphocytic leukemia.
- Alemtuzumab seems to be particularly effective in treating T-cell prolymphocytic leukemia. It may be used in people whose lymphoma is no longer responding to chemotherapy drugs like fludarabine.